These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11504543)

  • 1. Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.
    Kent SJ; Cameron PU; Reece JC; Thompson PR; Purcell DF
    Virology; 2001 Aug; 287(1):71-8. PubMed ID: 11504543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectivity of wild-type and deleted proviral SIV DNA.
    Purcell DF; Cameron PU; Mills J; Kent S
    Dev Biol (Basel); 2001; 106():395-406. PubMed ID: 11761255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
    Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
    Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J; Kräusslich HG
    FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-inactivating lentiviral vectors with U3 and U5 modifications.
    Iwakuma T; Cui Y; Chang LJ
    Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region.
    Xiao Y; Kuwata T; Miura T; Hayami M; Shida H
    Virology; 2000 Apr; 269(2):268-75. PubMed ID: 10753705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
    Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
    Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with attenuated simian immunodeficiency virus by DNA inoculation.
    Kent SJ; Dale CJ; Preiss S; Mills J; Campagna D; Purcell DF
    J Virol; 2001 Dec; 75(23):11930-4. PubMed ID: 11689679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
    Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
    J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activity of HERV-K-T47D-related long terminal repeats.
    Baust C; Seifarth W; Schön U; Hehlmann R; Leib-Mösch C
    Virology; 2001 May; 283(2):262-72. PubMed ID: 11336551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.
    Makarova O; Gorneva G; Wu F; Farutin V; Villeponteau B; Poliani L; Fink D; Levine M
    Gene Ther; 1996 Sep; 3(9):829-33. PubMed ID: 8875233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes.
    Parolin C; Taddeo B; Palú G; Sodroski J
    Virology; 1996 Aug; 222(2):415-22. PubMed ID: 8806525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-modulation of HIV-1 LTR activity by an extra-LTR nef gene fragment.
    Ludvigsen A; Werner T; Gimbel W; Erfle V; Brack-Werner R
    Virology; 1996 Feb; 216(1):245-51. PubMed ID: 8614997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.
    Zufferey R; Nagy D; Mandel RJ; Naldini L; Trono D
    Nat Biotechnol; 1997 Sep; 15(9):871-5. PubMed ID: 9306402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus.
    Thompson KA; Kent SJ; Gahan ME; Purcell DF; McLean CA; Preiss S; Dale CJ; Wesselingh SL
    J Neurovirol; 2003 Aug; 9(4):442-51. PubMed ID: 12907389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle.
    Young KR; Smith JM; Ross TM
    Virology; 2004 Oct; 327(2):262-72. PubMed ID: 15351214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
    Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
    Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
    Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
    Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.